Literature DB >> 28778982

Circular RNAs in rat models of cardiovascular and renal diseases.

Xi Cheng1, Bina Joe2.   

Abstract

Circular RNAs (circRNAs) have emerged as an important new class of genomic regulatory molecules contributing to the development of various diseases, but their relevance to the development and progression of hypertension remains largely unknown. A major impediment to begin studying circRNAs in rat models of inherited hypertension is that the rat as a valuable model of human diseases lags far behind the mouse and human in providing knowledge on circRNAs. In this study, a genome-wide circRNA profiling was performed from four rat strains that are widely used in hypertension research: the Dahl salt-sensitive rat (S), the Dahl salt-resistant rat (R), the spontaneously hypertensive rat (SHR), and the Wistar Kyoto rat (WKY). Combined hybridization data obtained from these four strains allowed for the identification of 12,846 circRNAs as being expressed in the rat kidneys. Out of these, 318 and 110 circRNAs were differentially expressed with a fold change > 1.5 (P < 0.05) in S vs. R and SHR vs. WKY, respectively. Among these circRNAs, circRNA/microRNA interaction was predicted since circRNAs are known as microRNA sponges to sequester microRNAs. Several circRNAs were further validated by quantitative real-time PCR. To our knowledge, our study is the primary report of profiling circRNAs in renal tissue and illustrates that circRNAs could be candidate genetic factors controlling blood pressure.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  blood pressure; circular RNAs; hypertension; rat; renal

Mesh:

Substances:

Year:  2017        PMID: 28778982      PMCID: PMC5625271          DOI: 10.1152/physiolgenomics.00064.2017

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  37 in total

Review 1.  Ion channels and the control of blood pressure.

Authors:  E H Baker
Journal:  Br J Clin Pharmacol       Date:  2000-03       Impact factor: 4.335

2.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

Review 3.  MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship.

Authors:  Amy E Pasquinelli
Journal:  Nat Rev Genet       Date:  2012-03-13       Impact factor: 53.242

4.  Mitogen-activated protein kinases as biomarkers of hypertension or cardiac pressure overload.

Authors:  María P Ocaranza; Jorge E Jalil
Journal:  Hypertension       Date:  2009-11-09       Impact factor: 10.190

5.  Rap1b in smooth muscle and endothelium is required for maintenance of vascular tone and normal blood pressure.

Authors:  Sribalaji Lakshmikanthan; Bartosz J Zieba; Zhi-Dong Ge; Ko Momotani; Xiaodong Zheng; Hayley Lund; Mykhaylo V Artamonov; Jason E Maas; Aniko Szabo; David X Zhang; John A Auchampach; David L Mattson; Avril V Somlyo; Magdalena Chrzanowska-Wodnicka
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-05-01       Impact factor: 8.311

6.  Wnt Signaling Regulates Blood Pressure by Downregulating a GSK-3β-Mediated Pathway to Enhance Insulin Signaling in the Central Nervous System.

Authors:  Pei-Wen Cheng; Ying-Ying Chen; Wen-Han Cheng; Pei-Jung Lu; Hsin-Hung Chen; Bo-Rong Chen; Tung-Chen Yeh; Gwo-Ching Sun; Michael Hsiao; Ching-Jiunn Tseng
Journal:  Diabetes       Date:  2015-04-16       Impact factor: 9.461

7.  A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223.

Authors:  Kun Wang; Bo Long; Fang Liu; Jian-Xun Wang; Cui-Yun Liu; Bing Zhao; Lu-Yu Zhou; Teng Sun; Man Wang; Tao Yu; Ying Gong; Jia Liu; Yan-Han Dong; Na Li; Pei-Feng Li
Journal:  Eur Heart J       Date:  2016-01-21       Impact factor: 29.983

8.  MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease.

Authors:  Yan Zhou; Ming Lu; Ren-Hong Du; Chen Qiao; Chun-Yi Jiang; Ke-Zhong Zhang; Jian-Hua Ding; Gang Hu
Journal:  Mol Neurodegener       Date:  2016-04-16       Impact factor: 14.195

9.  Microarray expression profile of circular RNAs in chronic thromboembolic pulmonary hypertension.

Authors:  Ran Miao; Ying Wang; Jun Wan; Dong Leng; Juanni Gong; Jifeng Li; Yan Liang; Zhenguo Zhai; Yuanhua Yang
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

10.  Genome sequencing reveals loci under artificial selection that underlie disease phenotypes in the laboratory rat.

Authors:  Santosh S Atanur; Ana Garcia Diaz; Klio Maratou; Allison Sarkis; Maxime Rotival; Laurence Game; Michael R Tschannen; Pamela J Kaisaki; Georg W Otto; Man Chun John Ma; Thomas M Keane; Oliver Hummel; Kathrin Saar; Wei Chen; Victor Guryev; Kathirvel Gopalakrishnan; Michael R Garrett; Bina Joe; Lorena Citterio; Giuseppe Bianchi; Martin McBride; Anna Dominiczak; David J Adams; Tadao Serikawa; Paul Flicek; Edwin Cuppen; Norbert Hubner; Enrico Petretto; Dominique Gauguier; Anne Kwitek; Howard Jacob; Timothy J Aitman
Journal:  Cell       Date:  2013-07-25       Impact factor: 41.582

View more
  13 in total

1.  Hsa_circ_0046159 is involved in the development of chronic thromboembolic pulmonary hypertension.

Authors:  Ran Miao; Juanni Gong; Chunyang Zhang; Ying Wang; Xiaojuan Guo; Jifeng Li; Suqiao Yang; Tuguang Kuang; Jiuchang Zhong; Huasong Feng
Journal:  J Thromb Thrombolysis       Date:  2020-04       Impact factor: 2.300

Review 2.  Epigenetics and vascular diseases.

Authors:  Matthew S Stratton; Floriana Maria Farina; Leonardo Elia
Journal:  J Mol Cell Cardiol       Date:  2019-06-15       Impact factor: 5.000

Review 3.  Animal Models of Hypertension: A Scientific Statement From the American Heart Association.

Authors:  Lilach O Lerman; Theodore W Kurtz; Rhian M Touyz; David H Ellison; Alejandro R Chade; Steven D Crowley; David L Mattson; John J Mullins; Jeffrey Osborn; Alfonso Eirin; Jane F Reckelhoff; Costantino Iadecola; Thomas M Coffman
Journal:  Hypertension       Date:  2019-06       Impact factor: 10.190

Review 4.  Circular RNAs in kidney disease and cancer.

Authors:  Anton Jan van Zonneveld; Malte Kölling; Roel Bijkerk; Johan M Lorenzen
Journal:  Nat Rev Nephrol       Date:  2021-08-11       Impact factor: 28.314

5.  circHLA-C Plays an Important Role in Lupus Nephritis by Sponging miR-150.

Authors:  Junjun Luan; Congcong Jiao; Weiwei Kong; Jingqi Fu; Wei Qu; Ying Chen; Xinwang Zhu; Yu Zeng; Guangying Guo; Huimeng Qi; Li Yao; Jingbo Pi; Lining Wang; Hua Zhou
Journal:  Mol Ther Nucleic Acids       Date:  2017-12-20       Impact factor: 8.886

Review 6.  Circular RNAs as novel biomarkers with regulatory potency in human diseases.

Authors:  Yuan Fang
Journal:  Future Sci OA       Date:  2018-05-23

Review 7.  Noncoding RNAs in Hypertension.

Authors:  Amela Jusic; Yvan Devaux
Journal:  Hypertension       Date:  2019-07-29       Impact factor: 10.190

8.  KHDRBS3 regulates the permeability of blood-tumor barrier via cDENND4C/miR-577 axis.

Authors:  Peiqi Wu; Yang Gao; Shuyuan Shen; Yixue Xue; Xiaobai Liu; Xuelei Ruan; Lianqi Shao; Yunhui Liu; Ping Wang
Journal:  Cell Death Dis       Date:  2019-07-11       Impact factor: 8.469

Review 9.  Circular RNA in renal diseases.

Authors:  Juan Jin; Haolu Sun; Chao Shi; Hui Yang; Yiwan Wu; Wanhai Li; Yu-Hang Dong; Liang Cai; Xiao-Ming Meng
Journal:  J Cell Mol Med       Date:  2020-04-25       Impact factor: 5.310

10.  Hsa_circ_0011385 accelerates the progression of thyroid cancer by targeting miR-361-3p.

Authors:  Fada Xia; Yong Chen; Bo Jiang; Ning Bai; Xinying Li
Journal:  Cancer Cell Int       Date:  2020-02-13       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.